INVO Fertility (NASDAQ:IVF) vs. Labcorp (NYSE:LH) Head to Head Comparison

INVO Fertility (NASDAQ:IVF) and Labcorp (NYSE:LH) are both healthcare companies, but which is the better investment? We will contrast the two companies based on the strength of their analyst recommendations, earnings, institutional ownership, profitability, valuation, dividends and risk.

Valuation & Earnings

This table compares INVO Fertility and Labcorp”s gross revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
INVO Fertility	$6.84 million	0.30	-$25.13 million	($33.83)	-0.02
Labcorp	$14.35 billion	1.74	$876.50 million	$12.09	25.52

Labcorp has higher revenue and earnings than INVO Fertility. INVO Fertility is trading at a lower price-to-earnings ratio than Labcorp, indicating that it is currently the more affordable of the two stocks.

Risk and Volatility

INVO Fertility has a beta of 2.39, suggesting that its share price is 139% more volatile than the S&P 500. Comparatively, Labcorp has a beta of 0.87, suggesting that its share price is 13% less volatile than the S&P 500.

Institutional and Insider Ownership

12.0% of INVO Fertility shares are owned by institutional investors. Comparatively, 95.9% of Labcorp shares are owned by institutional investors. 0.4% of INVO Fertility shares are owned by insiders. Comparatively, 0.8% of Labcorp shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Analyst Ratings

This is a summary of current ratings and target prices for INVO Fertility and Labcorp, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
INVO Fertility	1	0	0	1	2.50
Labcorp	0	3	9	0	2.75

INVO Fertility presently has a consensus price target of $20.00, suggesting a potential upside of 2,312.55%. Labcorp has a consensus price target of $337.73, suggesting a potential upside of 9.47%. Given INVO Fertility’s higher possible upside, analysts plainly believe INVO Fertility is more favorable than Labcorp.

Profitability

This table compares INVO Fertility and Labcorp’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
INVO Fertility	-116.29%	-85.54%	-31.05%
Labcorp	6.99%	16.74%	7.81%

Summary

Labcorp beats INVO Fertility on 12 of the 15 factors compared between the two stocks.

About INVO Fertility

INVO Bioscience, Inc., together with its subsidiary, a healthcare services fertility company, provides assisted reproductive technology solutions worldwide. It offers INVOcell, a medical device that allows fertilization and early embryo development to take place in vivo within the woman’s body. The company was founded in 2007 and is based in Sarasota, Florida.

About Labcorp

Labcorp Holdings, Inc. engages in providing medical testing services. The company was founded on April 16, 2024 and is headquartered in Burlington, NC.